Der Monoklonal Anti-Apolipoprotein M-Antikörper wurde für WB, ELISA und IF validiert. Er ist geeignet, Apolipoprotein M in Proben von Human zu detektieren. Es sind 3+ Publikationen verfügbar.
APOM
Reaktivität: Human
WB, ELISA, IF
Wirt: Maus
Monoclonal
2A8
unconjugated
Applikationshinweise
Western Blot: 1: 500- 1: 2,000 IF: 1: 200- 1: 1,000 ELISA: Propose dilution 1: 10,000. Determining optimal working dilutions by titration test.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Lagerung
-20 °C
Zhang, Jiao, Hurtig, Dong, Zheng, Luo, Nilsson-Ehle, Ye, Xu: "Expression pattern of apolipoprotein M during mouse and human embryogenesis." in: Acta histochemica, Vol. 106, Issue 2, pp. 123-8, (2004) (PubMed).
Duan, Dahlbäck, Villoutreix: "Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis." in: FEBS letters, Vol. 499, Issue 1-2, pp. 127-32, (2001) (PubMed).
Xu, Dahlbäck: "A novel human apolipoprotein (apoM)." in: The Journal of biological chemistry, Vol. 274, Issue 44, pp. 31286-90, (1999) (PubMed).
Target
Apolipoprotein M (APOM)
Andere Bezeichnung
ApoM
Hintergrund
ApoM(apolipoprotein M,also designated G3a or NG20),with 188-amino acid protein(about 21kDa),is an apolipoprotein and member of the lipocalin protein family. The Apo-proteins are involved in the specific binding of cellular receptors, the regulation of lipolytic enzymes, and the process of lipid exchange. The encoded protein is secreted through the plasma membrane but remains membrane-bound, where it is involved in lipid transport. The N-terminal region of Apo-M contains hydrophobic residues that may promote association with the phospholipid layer of lipoprotein particles. In vitro,Apo-M is glycosylated when translated in the presence of microsomes, and remains associated with the microsomes after carbonate treatment.Apo-M is expressed in liver and kidney, and is secreted into the bloodstream in HDLs,and also found in triglyceride-rich lipoproteins and LDLs.